Toggle Main Menu Toggle Search

Open Access padlockePrints

Decreased expression of gastrokine 1 and the trefoil factor interacting protein TFIZ1/GKN2 in gastric cancer: Influence of tumor histology and relationship to prognosis

Lookup NU author(s): Professor Bruce Westley, Dr Felicity May

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Purpose: Transcriptional profiling showed decreased expression of gastrokine 1 (GKN1) and the related trefoil factor interacting protein (TFIZ1/GKN2) in Helicobacter pylori infection. Decreased GKN1 and GKN2 mRNA expression has been reported in gastric adenocarcinoma. We have examined GKN1 and GKN2 protein expression in a large gastric cancer series, correlated expression with tumor subtype, and evaluated their utility as prognostic biomarkers. Experimental Design: GKN1, GKN2, and the trefoil factors TFF1 and TFF3 were examined in tissue microarrays from 155 distal gastric adenocarcinomas. Immunohistochemical expression was correlated with clinical outcome. GKN1 and GKN2 expression was measured by real-time PCR and Western analysis in samples of gastric cancer and adjacent nonneoplastic mucosa. Results: GKN1 was lost in 78% of diffuse and 42% of intestinal cancers (P < 0.0001, diffuse versus intestinal). GKN2 expression was lost in 85% of diffuse and 54% of intestinal type cancers (P < 0.002). GKN1 and GKN2 down-regulation were confirmed by Western and real-time PCR analysis. Loss of either protein was associated with significantly worse outcome in intestinal-type tumors by univariate analysis; and GKN2 loss remained a predictor of poor outcome in multivariate analysis (P < 0.033).TFF1 was lost in >70%, and TFF3 was expressed in similar to 50% of gastric cancers. Conclusions: Loss of GKN1 and GKN2 expression occurs frequently in gastric adenocarcinomas, especially in the diffuse subtype. GKN1 and GKN2 loss are associated with shorter overall survival in the intestinal subtype.


Publication metadata

Author(s): Moss SF, Lee JW, Sabo E, Rubin AK, Rommel J, Westley BR, May FEB, Gao J, Meitner PA, Tavares R, Resnick MB

Publication type: Article

Publication status: Published

Journal: Clinical Cancer Research

Year: 2008

Volume: 14

Issue: 13

Pages: 4161-4167

Print publication date: 01/07/2008

Acceptance date: 22/04/2008

ISSN (print): 1078-0432

ISSN (electronic): 1557-3265

Publisher: American Association of Cancer Research

URL: http://dx.doi.org/10.1158/1078-0432.CCR-07-4381

DOI: 10.1158/1078-0432.CCR-07-4381


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
P20 RR017695-057270NCRR NIH HHS
P20RR17695NCRR NIH HHS
R01 CA111533NCI NIH HHS
R01 CA111533-02NCI NIH HHS
P20 RR017695NCRR NIH HHS
R01CA111533NCI NIH HHS

Share